Trials
MRD trials
The curated index is a sourced list of studies. Accruing is the live ClinicalTrials.gov set of studies that are recruiting or not yet recruiting. DYNAMIC-III is not in the curated index because it is registered in Australia and New Zealand, not with an NCT id.
Recruiting and not-yet-recruiting studies that use ctDNA, cfDNA, or MRD in eligibility, a treatment decision, or a primary or secondary endpoint, plus observational studies focused on that testing. 1123 studies from 2267 registry records. Hematologic trials that list MRD only as a secondary endpoint are listed separately. Last synced Nov 18, 2026, 2:04 PM EST.
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma
Fudan University · 1 locations · Updated 2026-04-21
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
Allison O'Neill, MD · 5 locations · Updated 2026-02-24
Biomarker and Mechanism Study of Systemic Therapy in Unresectable HCC
Shanghai Zhongshan Hospital · Locations not reported · Updated 2026-09-02
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
University of California, Irvine · 1 locations · Updated 2026-08-31
On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer
Region Skane · 3 locations · Updated 2026-08-03
Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
University of Hawaii · 2 locations · Updated 2026-04-30
cfDNA Methylation for Liver Cancer Recurrence Detection
Wuhan Ammunition Life-tech Co., Ltd · 1 locations · Updated 2026-03-23
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA
Zhujiang Hospital · 7 locations · Updated 2026-03-20
Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma
Chinese University of Hong Kong · 1 locations · Updated 2026-03-04
ctDNA Monitoring in Patients With HCC and mCRC
Medical University of Warsaw · 1 locations · Updated 2025-06-03
Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy
Shanghai Zhongshan Hospital · 1 locations · Updated 2025-03-26
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
Second Affiliated Hospital, Zhejiang University, School of Medicine · 1 locations · Updated 2025-02-10
Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance
Tongji Hospital · 1 locations · Updated 2024-12-30
Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma
Zhujiang Hospital · 4 locations · Updated 2024-06-10
Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases
Changhai Hospital · 1 locations · Updated 2022-03-11
Status can change after this sync. The curated list is the other view on this page. Evidence holds the published results.